Human cord blood CD34+Pax-5+ B-cell progenitors: Single-cell analyses of their gene expression profiles

Blood

Volumn 101, Issue 9, 2003, Pages 3424-3430

  Sanz, Eva ^b   Alvarez Mon, Melchor ^b   Martinez A, Carlos ^b   De la Hera, Antonio ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE; RAG1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG; COMPLEMENT COMPONENT C3B RECEPTOR; DNA BINDING PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; PAX5 PROTEIN, HUMAN;

ARTICLE; CELL POPULATION; CELL SELECTION; CELL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEWBORN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CLASSIFICATION; CYTOLOGY; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; METABOLISM;

ANTIGENS, CD19; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; NEPRILYSIN; RECEPTORS, COMPLEMENT 3B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 0037528814     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-07-2244     Document Type: Article

References (43)

1. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989;86:3828-3832.
2. + progenitors to peripheral blood. J Exp Med. 1997;185:111-120.
3. Kohn DB, Weinberg KI, Nolta JA, et al. Engraftment of gene-modified umbilical cord cells in neonates with adenosine deaminase deficiency. Nat Med. 1995;1:1017-1023.
4. Garcia-Ortiz MJ, Serrano F, Abad JL, et al. ΔhGHR, a novel biosafe cell-surface labeling molecule for analysis and selection of genetically transduced human cells. Hum Gene Ther. 2000;11:333-346.
5. Lagasse E, Shizuru JA, Uchida N, Tsukamoto A, Weissman IL. Toward regenerative medicine. Immunity. 2001;14:425-436.
6. + hematopoietic cells. Exp Hematol. 1992;20:24-33.
7. + cell populations derived from umbilical cord blood using flow cytometry and cDNA-polymerase chain reaction. Blood. 1994;83:2103-2114.
8. Nunez C, Nishimoto N, Gartland GL, et al. B cells are generated throughout life in humans. J Immunol. 1996;156:866-872.
9. LeBien TW. Fates of human B cell precursors. Blood. 2000;96:9-23.
10. Ghia P, ten Boekel E, Sanz E, de Hera A, Rolink A, Melchers F. Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci. J Exp Med. 1996;184:2217-2229.
11. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for retention of B-lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10:463-471.
12. Dorshkind K. Understanding how pre-B cells come of age. Nat Immunol. 2000;1:369-370.
13. King LB, Cambier JG. B cell receptor rehabilitation - pausing to reflect. Science. 2001;291:1503-1505.
14. + cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 1991;77:2591-2596.
15. Fluckiger AC, Sanz E, Garcia-Lloret M, et al. In vitro reconstitution of human B cell ontogeny: from CD34 multipotent progenitors to Ig-secreting cells. Blood. 1998;92:4509-4520.
16. Wang YH, Stephan RP, Scheffold A, et al. Differential surrogate light-chain expression governs B-cell differentiation. Blood. 2002;99:2459-2467.
17. Honczarenko M, Douglas RS, Mathias C, Lee B, Ratajczak MZ, Silberstein LE. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood. 1999;94:2990-2998.
18. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature. 1999;401:556-562.
19. Cory S. Wavering on commitment. Nature. 1999;401:538-539.
20. Nutt SL, Morrison A-M, Dörfler P, Rolink AG, Busslinger M. Identification of BSAP (Pax5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 1998;17:2319-2333.
21. Dworzak MN, Fritsch G, Fröschl G, Printz D, Gadner H. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B cell ontogeny. Blood. 1998;92:3203-3209.
22. Ryan DH, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Insel RA. Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity. Blood. 1997;89:929-940.
23. Bertrand FE III, Billips LG, Burrows PD, Gartland GL, Kubagawa H, Schroeder HW Jr. Ig DH gene segment transcription and rearrangement before surface expression of the pan-B-cell marker CD19 in normal human bone marrow. Blood. 1997;90:736-744.
24. Bruno L, Res P, Dessing M, Cella M, Spits H. Identification of a committed T cell precursor population in adult human peripheral blood. J Exp Med. 1997;185:875-884.
25. Coustan-Smith E, Behm FG, Sanchez J, et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukemia. Lancet. 1998;351:550-554.
26. Meffre E, Davis E, Schifl C, et al. Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol. 2000;1:207-213.
27. Benedict CL, Gilfilian S, Thai TH, Kearney JF. Terminal deoxynucleotidyl transferase and repertoire development. Immunol Rev. 2000;175:150-157.
28. Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med. 1991;173:395-407.
29. Ramiro AR, Trigueros C, Marquez C, San Millan JL, Toribio ML. Regulation of pre-T cell receptor (pTα-TCRβ) gene expression during human thymic development. J Exp Med. 1996;184:519-530.
30. Res PC, Couwenberg F, Vith-Dreese FA, Spits H. Expression of pTα mRNA in a committed dendritic cell precursor in the human thymus. Blood. 1999;94:2647-2657.
31. Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 1995;3:459-473.
32. Hao QL, Zhu J, Price MA, Payne KJ, Barsky LW, Crooks GM. Identification of a novel, human multilymphoid progenitor in cord blood. Blood. 2001;97:3683-3690.
33. Rolink AG, Winkler T, Melchers F, Anderson J. Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med. 2000;191:23-31.
34. Meflre E, Chiorazzi M, Nussenzweig M. Circulating human B cells that express surrogate light chains display a unique antibody repertoire. J Immunol. 2001;167:2151-2156.
35. Shulman MJ, Wu GE. Hypothesis: genes which function in a stochastic lineage commitment process are subject to monoallelic expression. Semin Immunol. 1999;11:369-371.
36. Enver T, Greaves M. Loops, lineage and leukemia. Cell. 1998;94:9-12.
37. Rowley JD. Backtracking leukemia to birth. Nat Med. 1998;4:150-151.
38. Greaves M. Molecular genetics, natural history and the demise of childhood leukemia. Eur J Cancer. 1999;35:1941-1953.
39. Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukemias. Nature. 1993;363:358-360.
40. Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood. 1997;90:2863-2892.
41. Uckun FM, Ledbetter JA. Immunobiologic differences between normal and leukemic human B-cell precursor. Proc Natl Acad Sci U S A. 1988;85:8603-8607.
42. Clarkson B, Boyse EA. Possible explanation of the high concordance for acute leukemia in monozygous twins. Lancet. 1971;1:699-701.
43. Hiom K, Melek M, Gellert M. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell. 1998;94:463-470.